Literature DB >> 17067649

Structural and functional characterization of a recombinant sticholysin I (rSt I) from the sea anemone Stichodactyla helianthus.

F Pazos1, A Valle, D Martínez, A Ramírez, L Calderón, A Pupo, M Tejuca, V Morera, J Campos, R Fando, F Dyszy, S Schreier, E Horjales, C Alvarez, M E Lanio, E Lissi.   

Abstract

Sticholysins I and II (Sts I and II) are two potent cytolysins from the sea anemone Stichodactyla helianthus. These isoforms present 13 substitutions, with three non-conservative located at the N-terminus. St II is considerably more hemolytic than St I in human red blood cells, a result explained by the smaller number of negatively charged groups present at St II's N-terminus. In the present work, we have obtained a recombinant St I (rSt I), differing from the wild type in a single amino acid residue (E16Q). This pseudo-wild type is structurally similar to St I and shows a similar capacity to interact with and form pores in model membranes. This was assessed by the intrinsic fluorescence increase in the presence of liposomes, their adsorption to bilayers (measured by SPR), their concentration at the air-water interface, their interaction with lipid monolayers and their capacity to promote the release of carboxyfluorescein entrapped in liposomes. In spite of these similarities, rSt I presents a larger hemolytic activity in human red blood cells than St I, being intermediate in activity between Sts I and II. The results obtained in the present work emphasize that even the change of one single E by Q at the N-terminal segment may modify the toxin HA and show that this functional property is the most sensitive to subtle changes in the protein primary structure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067649     DOI: 10.1016/j.toxicon.2006.09.004

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Disrupting a key hydrophobic pair in the oligomerization interface of the actinoporins impairs their pore-forming activity.

Authors:  Haydeé Mesa-Galloso; Karelia H Delgado-Magnero; Sheila Cabezas; Aracelys López-Castilla; Jorge E Hernández-González; Lohans Pedrera; Carlos Alvarez; D Peter Tieleman; Ana J García-Sáez; Maria E Lanio; Uris Ros; Pedro A Valiente
Journal:  Protein Sci       Date:  2017-02-23       Impact factor: 6.725

2.  Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response.

Authors:  Rady J Laborde; Oraly Sanchez-Ferras; María C Luzardo; Yoelys Cruz-Leal; Audry Fernández; Circe Mesa; Liliana Oliver; Liem Canet; Liane Abreu-Butin; Catarina V Nogueira; Mayra Tejuca; Fabiola Pazos; Carlos Álvarez; María E Alonso; Ieda M Longo-Maugéri; Michael N Starnbach; Darren E Higgins; Luis E Fernández; María E Lanio
Journal:  J Immunol       Date:  2017-03-03       Impact factor: 5.422

3.  Mutagenesis and functional analysis of the pore-forming toxin HALT-1 from Hydra magnipapillata.

Authors:  Yvonne Jing Mei Liew; Wai Tuck Soh; William Febry Jiemy; Jung Shan Hwang
Journal:  Toxins (Basel)       Date:  2015-02-03       Impact factor: 4.546

4.  Functional characterization of sticholysin I and W111C mutant reveals the sequence of the actinoporin's pore assembly.

Authors:  Valeria Antonini; Victor Pérez-Barzaga; Silvia Bampi; David Pentón; Diana Martínez; Mauro Dalla Serra; Mayra Tejuca
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

5.  Self-homodimerization of an actinoporin by disulfide bridging reveals implications for their structure and pore formation.

Authors:  Aisel Valle; Luis Benito Pérez-Socas; Liem Canet; Yadira de la Patria Hervis; German de Armas-Guitart; Diogo Martins-de-Sa; Jônatas Cunha Barbosa Lima; Adolfo Carlos Barros Souza; João Alexandre Ribeiro Gonçalves Barbosa; Sonia Maria de Freitas; Isabel Fabiola Pazos
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

6.  Anticancer Activity of Anthopleura anjunae Oligopeptides in Prostate Cancer DU-145 Cells.

Authors:  Zong-Ze Wu; Guo-Fang Ding; Fang-Fang Huang; Zui-Su Yang; Fang-Miao Yu; Yu-Ping Tang; Ying-Lu Jia; Yuan-Yuan Zheng; Rui Chen
Journal:  Mar Drugs       Date:  2018-04-12       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.